Kevin Brumett
“Since every death diminishes us a little, we grieve – not so much for the death as for ourselves.” Lynn Caine
It is with heaviness of heart that we inform you of Kevin Brumett. On Thursday, May 28, 2009, Kevin passed away at his home in Newton, MA after a valiant fight with non-small cell lung cancer.
Kevin Brumett’s story is featured in the Public TV documentary “Breath of Hope.” He was a relentless warrior for lung cancer research and awareness. Kevin fought hard to allay the anguish and break the stigma associated with lung cancer. His will to live was inspiring, giving hope to countless patients around the world.
Kevin, the son of Frederick Brumett and the late Donna (Lonergan) Brumett, was born in Rockville, CT, on November 29, 1977. He received his undergraduate degree from the University of Connecticut in 2000, and worked for a pharmaceutical company in Andover, MA. Four years ago, Kevin moved from South Windsor, CT to Boston, MA where he met his future wife, Stephanie Fellingham Brumett. Kevin enjoyed fishing, music, movies, and spending time with his many friends.
In addition to his wife and father, Kevin leaves his loving sister, Tricia Smith, her husband, Matthew, and their daughter Kierian of Port St. Lucie, FL. Also surviving is his father’s fiancee Cathy Rossetti and her children, Christina, Cynthia, Cassandra and Richard Rossetti. Kevin also leaves an innumerable amount of friends who were with him every step of the way, walking (and sometimes running) beside him.
Kevin Brumett was 31 years old.
About “Breath of Hope”
GET THE DVD TODAY!
They are your friends, your relatives, your neighbors - people you recognize and greet every day. People you love.
They are also the thousands of nameless people you may encounter during the course of a lifetime. Some of these people are or will become members 
of an exclusive but grim club, a club that no one willingly chooses to join. The only requirement for membership is a diagnosis of non-small-cell-lung cancer. And the dues are heartbreaking.
BREATH OF HOPE: Lung Cancer The Invisible Disease is an hour-long documentary seeking to educate the public about lung cancer – in particular non-small cell lung cancer. Through five poignant patient stories in five different states across the U.S., viewers witness the struggles and triumphs of lung cancer patients and their families. 
The documentary also explores new therapies on the horizon and the latest genetic markers that may offer hope for extending survival. 
Emmy and Golden Globe Award-winning American actress S. Epatha Merkerson, best known as Lt. Anita Van Buren on the long-running television crime drama Law & Order, hosts the documentary. Merkerson lost two friends to lung cancer and helped her sister fight her way to a cure. The program will air on Public Television. Click here for air dates and times.
NEWS: Phase III Development of Non Small Cell Lung Cancer Treatment Extended to Japan
London, UK, and Cambridge, MA (March 25, 2009) - Antisoma plc announces that ATTRACT-1, the Novartis phase III trial evaluating ASA404 as a first-line treatment for non-small cell lung cancer, is now enrolling patients in Japan. ATTRACT-1 has been enrolling patients in a variety of other countries since it began in April 2008. Extension of the trial to Japan follows the successful completion of a phase I study evaluating the safety of ASA404 in Japanese lung cancer patients.
NEWS: Surviving Lung Cancer
ScienceDaily (Mar. 12, 2009) — Countless people have heard the phrase, “You have lung cancer,” but only 50 can say they’ve completed a new treatment at Temple University that doubles their chances of surviving the deadly disease — and without the conventional radiation regimen or surgery.
Doctors in the Radiation Oncology Department say the technique, stereotactic body radiotherapy, or SBRT, not only improves a person’s odds of surviving early stage lung cancer, but may reduce the need for future surgeries.
“This is a big trend in radiation oncology for early stage lung cancer patients who either can’t undergo surgery or refuse it,” says Curtis Miyamoto, M.D., chair and professor of the Department of Radiation Oncology at the School of Medicine. “With the success of this technique, we’re now questioning whether we’ll even be doing surgeries on these patients in the future.”
NEWS: Breath Or Urine Analysis May Detect Cancer, Diabetes
ScienceDaily (Mar. 11, 2009) — A future sensor may take away a patient’s breath while simultaneously determining whether the patient has breast cancer, lung cancer, diabetes or asthma. A University of Missouri researcher is developing a device that will analyze breath or urine samples for volatile markers inside the body that indicate disease.
These volatile markers, such as alkanes, acetones or nitric oxide, give doctors clues about what is happening inside the body and can be used as a diagnostic tool.
“Little traces of certain gas molecules in the breath or urine tell us if anything unusual is going on in the body,” said Xudong “Sherman” Fan, investigator in the Christopher S. Bond Life Sciences Center. “Measuring these volatile markers would be a non-invasive way to determine if a disease is present without having to draw blood or complete a biopsy. In addition to the biomarkers already discovered, many more potential volatile markers are still under investigation.”